In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Johnson & Johnson displays a 29.5% implied upside with high-confidence valuations, suggesting undervaluation relative to a current price of $238.33. Strong profitability and leverage scores contrast with low growth, while Monte Carlo results reveal substantial volatility and a 42.9% downside risk below current price. Diverse valuation methods and scenario ranges imply moderate risk with potential for significant upside.